The role of the mostly immunosuppressive cytokine IL-10 in dampening the immune response to pneumococcal infection was shown in 1996, when van der Poll et al. administered the pathogen intranasally together with IL-10 and observed early mortality and reduced levels of the pro-inflammatory factors IFN-γ and TNF. Here, IL10 is linked to pneumococcal infection.